Chapter 2

Connecticut Mental Health Center: Clinical, Research and Training Programs in the Addictions

Richard Schottenfeld MD

Richard Schottenfeld MD

Professor of Psychiatry

Yale University School of Medicine, USA

Search for more papers by this author
Kathleen Carroll PhD

Kathleen Carroll PhD

Professor of Psychiatry Director of Psychosocial Research

Yale University School of Medicine, USA

Division of Substance Abuse, Veterans, Administration Medical Center, West Haven, CT, USA

Search for more papers by this author
Thomas Kosten MD

Thomas Kosten MD

Professor of Psychiatry and Neuroscience

Baylor University College of Medicine, Houston, TX, USA

Search for more papers by this author
Stephanie O'Malley PhD

Stephanie O'Malley PhD

Professor of Psychiatry Director

Yale University School of Medicine, USA

Division of Substance Abuse Research, Substance Abuse Treatment Unit, Connecticut Mental Health Center, USA

Search for more papers by this author
Bruce Rounsaville MD

Bruce Rounsaville MD

Professor of Psychiatry Director

Yale University School of Medicine, USA

VISN 1 Mental Illness Research Education and Clinical Center, VA, USA

Connecticut Healthcare, West Haven, Connecticut, USA

Search for more papers by this author
Rajita Sinha PhD

Rajita Sinha PhD

Professor of Psychiatry Director

Yale University School of Medicine, USA

Research Program on Stress, Addiction and Psychopathology, Connecticut Mental Health Center, USA

Search for more papers by this author
Herbert Kleber MD

Herbert Kleber MD

Professor of Psychiatry Director

College of Physicians and Surgeons, Columbia, USA

University of the City of New York, USA

Division on Substance Abuse, New York State Psychiatric Institute, USA

Search for more papers by this author
First published: 14 December 2007

Summary

This chapter contains sections titled:

  • Addiction treatment services

  • Satu leadership, faculty development and training

  • Research accomplishments

  • Depression and other psychiatric disorders in addicted individuals

  • Naltrexone and psychotherapy for alcohol dependence

  • Opioid antagonists and nicotine dependence

  • Pharmacologic treatments for cocaine dependence

  • Behavioral treatments for cocaine and other addictive disorders

  • Buprenorphine in the treatment of drug abuse

  • Gender differences

  • Addictions treatment protocols in primary care medical clinics

  • Implications for public psychiatry

  • Conclusion

  • References

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.